Trial intelligence / Profile preview

Ferric maltol oral iron supplementation in pulmonary hypertension with iron deficiency anemia

2016-005100-26Phase 3Completed

Sponsor
Hannover Medical School
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric maltol in iron deficiency anemia (IDA), sponsored by Hannover Medical School. Started Jul 2017; status: completed.

02

Drugs

ferric maltol
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on 2016-005100-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-005100-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call